Open-Label Study of 18F-mFBG for Imaging Myocardial Sympathetic Innervation
Status:
Not yet recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
This is a Phase 1/2 study evaluating the positron-emitting radiopharmaceutical 18F-mFBG as an
imaging agent for quantification of myocardial sympathetic innervation.